HCPLive Network

Ulcerative Colitis

Interim study results presented at ACG 2014 indicate that treatment with vedolizumab safely and effectively maintains long-term clinical remission and response in patients with Crohn’s disease and ulcerative colitis.
Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.
Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
A formal yoga program may be beneficial for pediatric patients newly diagnosed with inflammatory bowel disease, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.
Uceris (budesonide) is now approved in a new dose for the induction of remission in patients afflicted with active mild-to-moderate distal ulcerative colitis.
Scientists in Germany have discovered a causal relationship between psychological factors and symptoms of irritable bowel syndrome (IBS) after viewing high rates of anxiety and depression among IBS patients.
Ulcerative Colitis Upcoming Events
Ulcerative Colitis Latest News
Ulcerative Colitis Clinical Trials
Ulcerative Colitis Resources